Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 176,983Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 7Copaxone

PharmaCompass

01

Brand Name : Copaxone

Glatiramer acetate

arrow
2024 ACI Convention
Not Confirmed

Brand Name : Copaxone

arrow
2024 ACI Convention
Not Confirmed

Glatiramer acetate

Main Therapeutic Indication : CNS & Anesthesia

Currency : USD

2019 Revenue in Millions : 1,512

2018 Revenue in Millions : 2,366

Growth (%) : -36

blank

02

Brand Name : Copaxone

Glatiramer acetate

arrow
2024 ACI Convention
Not Confirmed

Brand Name : Copaxone

arrow
2024 ACI Convention
Not Confirmed

Glatiramer acetate

Main Therapeutic Indication : CNS & Anesthesia

Currency : USD

2020 Revenue in Millions : 1,337

2019 Revenue in Millions : 1,512

Growth (%) : -12

blank

03

Brand Name : Copaxone

Glatiramer acetate

arrow
2024 ACI Convention
Not Confirmed

Brand Name : Copaxone

arrow
2024 ACI Convention
Not Confirmed

Glatiramer acetate

Main Therapeutic Indication : Neurology

Currency : USD

2021 Revenue in Millions : 1,005

2020 Revenue in Millions : 1,337

Growth (%) : -25

blank

04

Brand Name : Copaxone

Glatiramer Acetate

arrow
2024 ACI Convention
Not Confirmed

Brand Name : Copaxone

arrow
2024 ACI Convention
Not Confirmed

Glatiramer Acetate

Main Therapeutic Indication : Neurology

Currency : USD

2022 Revenue in Millions : 691

2021 Revenue in Millions : 1,005

Growth (%) : -31

blank

05

Brand Name : Copaxone

Glatiramer Acetate

arrow
2024 ACI Convention
Not Confirmed

Brand Name : Copaxone

arrow
2024 ACI Convention
Not Confirmed

Glatiramer Acetate

Main Therapeutic Indication : Neurology

Currency : USD

2023 Revenue in Millions : 590

2022 Revenue in Millions : 691

Growth (%) : -15

blank

06

Brand Name : Copaxone

Glatiramer Acetate

arrow
2024 ACI Convention
Not Confirmed

Brand Name : Copaxone

arrow
2024 ACI Convention
Not Confirmed

Glatiramer Acetate

Main Therapeutic Indication : Neurological/Mental Disorders

Currency : USD

2017 Revenue in Millions : 3,801

2016 Revenue in Millions : 4,223

Growth (%) : -10

blank

07

Brand Name : Copaxone

Glatiramer Acetate

arrow
2024 ACI Convention
Not Confirmed

Brand Name : Copaxone

arrow
2024 ACI Convention
Not Confirmed

Glatiramer Acetate

Main Therapeutic Indication : Neurological/Mental Disorders

Currency : USD

2018 Revenue in Millions : 2,366

2017 Revenue in Millions : 3,802

Growth (%) : -38%

blank